Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements 2024
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show 2025
Spring on the Road
Spring Wellness 2025
Canada Votes 2025
2024 Readers' Choice Awards
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
Ontario Votes
LAST CHANCE AUCTION
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Corvus Pharmaceuticals, Inc. - Common Stock
(NQ:
CRVS
)
4.430
+1.080 (+32.24%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Corvus Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
12 Health Care Stocks Moving In Friday's Intraday Session
Today 13:06 EDT
Via
Benzinga
Corvus Gets Price Target Hike From Oppenheimer On Positive Drug Trial Results: Retail’s Pleased
Today 12:48 EDT
Corvus announced new interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis.
Via
Stocktwits
Why Is Corvus Pharmaceuticals Stock Soaring On Friday?
Today 11:57 EDT
Corvus Pharmaceuticals, Inc.(NASDAQ:CRVS) on Thursday released new interim data from the Phase 1 clinical trial evaluating ...
Via
Benzinga
Wondering what's happening in today's pre-market session?
Today 10:30 EDT
Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.
Via
Chartmill
Earnings Scheduled For May 8, 2025
May 08, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
November 12, 2024
Via
Benzinga
An Overview of Corvus Pharma's Earnings
November 11, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Today 8:10 EDT
Via
Benzinga
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket
Today 5:33 EDT
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Thursday?
May 08, 2025
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's After-Market Session
May 08, 2025
Via
Benzinga
These stocks are gapping in today's session
March 26, 2025
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.
Via
Chartmill
Corvus Pharma Stock Dips On Bigger-Than-Feared Q4 Loss, But Retail’s Faith Grows Stronger
March 25, 2025
Research and development expenses in the reported quarter rose by $2 million, primarily due to increased spending on the soquelitinib clinical trial for T-cell lymphoma.
Via
Stocktwits
Earnings Scheduled For March 25, 2025
March 25, 2025
Via
Benzinga
This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday
January 02, 2025
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 18, 2024
Via
Benzinga
Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday?
December 18, 2024
Corvus Pharmaceuticals shares interim Phase 1 trial data showing promising results for soquelitinib in treating moderate to severe atopic dermatitis.
Via
Benzinga
Crude Oil Gains Over 1%, General Mills Shares Fall
December 18, 2024
Via
Benzinga
Exposures
Fossil Fuels
Dow Surges 150 Points, US Current Account Deficit Widens In Q3
December 18, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session
December 18, 2024
Via
Benzinga
US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak
December 18, 2024
U.S. stock futures climbed on Wednesday as Wall Street awaits the Fed's final interest rate decision and its monetary policy forecasts for 2025.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
December 18, 2024
Via
Benzinga
Stellantis, MicroStrategy, Bit Digital And Other Big Stocks Moving Lower In Monday's Pre-Market Session
September 30, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
September 30, 2024
Via
Benzinga
Why Nio Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
September 30, 2024
Via
Benzinga
Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
September 18, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Alcoa, Lattice Semiconductor, Stratasys And Other Big Stocks Moving Higher On Monday
September 16, 2024
Via
Benzinga
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
August 07, 2024
Via
Benzinga
The 2024 Millionaire’s Club: 3 Penny Stocks to Buy Now
May 31, 2024
One of the best ways to spot opportunity in penny stocks to buy is by following insiders. Here are three to consider.
Via
InvestorPlace
CRVS Stock Earnings: Corvus Pharma Misses EPS for Q1 2024
May 06, 2024
CRVS stock results show that Corvus Pharma missed analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.